Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
CNY 65.41
(0.17%)
CNY 65.41
(0.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.47 Billion CNY | -51.03% |
| 2022 | 11.18 Billion CNY | 94.51% |
| 2021 | 5.75 Billion CNY | 144.25% |
| 2020 | 2.35 Billion CNY | 98.88% |
| 2019 | 1.18 Billion CNY | 20.46% |
| 2018 | 982.68 Million CNY | 3.49% |
| 2017 | 949.52 Million CNY | 12.49% |
| 2016 | 844.08 Million CNY | 24.0% |
| 2015 | 680.71 Million CNY | 14.17% |
| 2014 | 596.23 Million CNY | 19.47% |
| 2013 | 499.06 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 749.56 Million CNY | 40.42% |
| 2024 Q3 | 582.06 Million CNY | -3.78% |
| 2024 Q2 | 604.96 Million CNY | -19.29% |
| 2023 Q4 | 533.79 Million CNY | -33.71% |
| 2023 Q1 | 2.88 Billion CNY | 13.88% |
| 2023 FY | 5.47 Billion CNY | -51.03% |
| 2023 Q2 | 1.27 Billion CNY | -55.76% |
| 2023 Q3 | 805.25 Million CNY | -36.94% |
| 2022 Q1 | 3.17 Billion CNY | 47.2% |
| 2022 Q4 | 2.53 Billion CNY | -6.84% |
| 2022 Q3 | 2.72 Billion CNY | -1.37% |
| 2022 Q2 | 2.75 Billion CNY | -13.01% |
| 2022 FY | 11.18 Billion CNY | 94.51% |
| 2021 Q3 | 1.63 Billion CNY | 43.17% |
| 2021 Q4 | 2.15 Billion CNY | 32.01% |
| 2021 Q1 | 824.02 Million CNY | 9.14% |
| 2021 FY | 5.75 Billion CNY | 144.25% |
| 2021 Q2 | 1.13 Billion CNY | 38.34% |
| 2020 Q3 | 755.52 Million CNY | 41.8% |
| 2020 Q1 | 310.89 Million CNY | -12.04% |
| 2020 FY | 2.35 Billion CNY | 98.88% |
| 2020 Q2 | 532.81 Million CNY | 71.38% |
| 2020 Q4 | 755.01 Million CNY | -0.07% |
| 2019 Q2 | 273.09 Million CNY | 9.0% |
| 2019 Q3 | 306.67 Million CNY | 12.29% |
| 2019 FY | 1.18 Billion CNY | 20.46% |
| 2019 Q4 | 353.44 Million CNY | 15.25% |
| 2019 Q1 | 250.54 Million CNY | -5.57% |
| 2018 Q1 | 226.03 Million CNY | 0.0% |
| 2018 FY | 982.68 Million CNY | 3.49% |
| 2018 Q4 | 265.31 Million CNY | 0.0% |
| 2018 Q3 | 265.31 Million CNY | 17.38% |
| 2018 Q2 | 226.03 Million CNY | 0.0% |
| 2017 FY | 949.52 Million CNY | 12.49% |
| 2016 FY | 844.08 Million CNY | 24.0% |
| 2015 FY | 680.71 Million CNY | 14.17% |
| 2014 FY | 596.23 Million CNY | 19.47% |
| 2013 FY | 499.06 Million CNY | 0.0% |